Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year

GSK’s pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly becoming treatment-resistant.
Good news for the millions of women who struggle with urinary tract infections (UTIs). The Food and Drug Administration (FDA) has approved a new drug, Blujepa, the first of a new class of oral antibiotics for treating UTIs, to head to market. Drugmaker GSK plans to release the drug in the U.S. in the second half of 2025.https://www.fastcompany.com/91306349/blujepa-new-uti-treatment-antibiotic-wins-fda-approval-urinary-tract-infection